Addus Homecare's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Addus Homecare's ROA in the third quarter of 2026?
Addus Homecare Corp achieved a return on average assets (ROA) of 7.74 % in its third quarter of 2026, this is above ADUS's average return on assets of 6.2%.
Addus Homecare Corp assets over the 12 months ending in its third quarter of 2026 are valued at $1,435 million

ROA has improved compared to 7.37% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 122 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 901, from total ROA ranking in the second quarter of 2026 at 1070.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	1.98 %	3.45 %	-0.92 %	1.43 %	28.11 %
Y / Y Net Income Change	25.15 %	25.19 %	18.09 %	52.52 %	13.32 %
Net Income (TTM) in million	111	105	100	96	86
Return On Assets (TTM)	7.74 %	7.37 %	7.04 %	6.76 %	6.06 %
ADUS's Total Ranking	# 901	# 1070	# 1027	# 1007	# 1003
Total Assets (TTM) in million	1,451	1,458	1,395	1,437	1,423
Seq. Total Assets Change	-0.45 %	4.51 %	-2.96 %	1.01 %	0.99 %
Seq. Net Income Change	3.58 %	10.12 %	-15.82 %	30.35 %	3.61 %

ADUS's 5 Years Annual ROA >> Back to ADUS Management Effectiveness >> Compare ADUS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 123
Overall	# 855

Return On Assets Statistics
High	Average	Low
14.36 %	6.2 %	3.5 %
(Sep 30 2013)		(Sep 30 2016)

Financial Statements
Addus Homecare's Assets	$ 1,451 million	ADUS's Balance sheet
Addus Homecare's Income	$ 29 million	Quarterly ADUS's Income Statement
ADUS's Income by Division		See ADUS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	2.07 %	39.46 %	8.9 %	-1.37 %	16.57 %
Total Assets in million	1,394	1,365	979	899	912
Y / Y Net Income Change	30.32 %	17.73 %	35.83 %	1.99 %	36.2 %
Net Income in million	96	74	63	46	45
Annual Return On Assets	6.88 %	5.39 %	6.39 %	5.12 %	4.95 %

ADUS's 5 Years Annual ROA >> Back to ADUS Management Effectiveness >> Compare ADUS ROA to its Competitors

Comment on ADUS's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 6.88 % compared to prior year, due to annual net income growth of 30.32 % to $95.91 million, while value of Addus Homecare's overall assets grew just by 2.07 % to $1,393.60 million, compared to $1,393.60 a year before.

More Return On Assets Ratios
ADUS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ADUS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ADUS's Competitors
Subscribers only: Roa for Addus Homecare's Suppliers
Subscribers only: Return On Assets for ADUS's Customers

You may also want to know
ADUS's Roi	ADUS's Inventory Turnover Ratio	ADUS's Growth Rates	ADUS's Dividend Comparisons
	ADUS's Profitability Ratios	ADUS's Asset Turnover Ratio	ADUS's Dividend Growth
ADUS's Roe	ADUS's Valuation Ratios	ADUS's Financial Strength Ratios	ADUS's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %

Date modified: 2026-11-06T12:58:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.